| • |
Predictors of Restenosis After Placement
of Drug-Eluting Stents in One or More Coronary Arteries (Am J Cardiol
97 (2005) 506-511) |
| • |
Comparison of Sirolimus-Eluting Stent, Paclitaxel-Eluting
Stent, and Bare Metal Stent in the Treatment of Long Coronary Lesions
(CCI 67 (2006) 181-187) |
| • |
The Preventive Effect on In-Stent Restenosis of Overlapped
Drug-Eluting Stents for Treating Diffuse Coronary Artery Disease (The
Korean Circulation Journal 36 (2006) 17-23) |
| • |
Elevated Preprocedural High-Sensitivity C-Reactive
Protein Levels are Associated With Neointimal Hyperplasia and Restenosis
Development After Successful Coronary Artery Stenting (Circulation
J 69 (2005) 1477-1483) |
| • |
The Long-Term Clinical Outcomes of Combination Therapy
with AngiotensinII Type 1 Receptor Blockerand Simvastatin after Percutaneous
Coronary Intervention (The Korean Circulation Journal 35 (2005) 877-882) |
| • |
The Clinical Results of a Platelet Glycoprotein IIb/IIIa
Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute Myocardial
Infarction Thrombosis (J Am Coll Cardiol 47 (2006) 933-938) |
| • |
Comparison of the Effectiveness of Sirolimus - and
Paclitaxel - Eluting Stents for Small Coronary Artery Lesions (CCI
67 (2006) 589-594) |
| • |
Safety and Efficacy with Drug-Eluting Stent in ST-Segment
Elevation and Non-ST-Segment Elevation Myocardial Infarction (Clinical
Cardiology 29 (2006) 199-203) |
| • |
The predictive factor of mortality and prognosis of
cardiovascular patients admitted at coronary care unit (The Korean
Journal of Medicine 70 (2006) 386-392) |
| • |
Comparison of Simple and Complex Stenting Techniques
in the Treatment of Unprotected Left Main Coronary Artery Bifurcation
Stenosis (Am J Cardiol 97(2006) 1597-1601) |
| • |
Intravascular ultrasound predictors of angiographic
restenosis after sirolimus-eluting stent implantation (European Heart
Journal 27(2006) 1305-1310) |
| • |
Frequency of and Risk Factors for Stent Thrombosis
After Drug-Eluting Stent Implantation During Long-Term Follow-Up (Am
J Cardiol 98 (2006) 352-356) |
| • |
Usefulness of Follow-up Low-Density Lipoprotein Cholesterol
Level as an Independent Predictor of Changes of Coronary Atherosclerotic
Plaque Size as Determined by Intravascular Ultrasound Analysis After
Statin(Atorvastatin or Simvastatin) Therapy (Am J Cardiol 98 (2006)
866-870) |
| • |
Clinical and Angiographic Outcomes After Placement
of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions
(Am J Cardiol 98 (2006) 918-922) |
| • |
The Effect of Alpha Lipoic Acid(Thioctacid HR) on Endothelial
Function in Diabetic and Hypertensive Patients. (The Korean Circulation
Journal 36 (2006) 559-564) |
| • |
Clinical Significance of Aortic Knob Width and Calcification
in Unstable Angina (Circulation J 70 (2006) 1280-1283) |
| • |
Effect of Combination Therapy With Simvastatin and
Carvedilol in Patients With Left Ventricular Dysfunction Complicated
With Acute Myocardial Infarction Who Underwent Percutaneous Coronary
Intervention (Circulation J 70 (2006) 1269-1274) |
| • |
Comparison With Conventional Therapies of Repeated
Sirolimus-Eluting Stent Implantation for the Treatment of Drug-Eluting
Coronary Stent Restenosis (Am J Cardiol 98 (2006) 1451-1454) |
| • |
Plaque ruptures in stable angina pectoris compared
with acute coronary syndrome (Int J of Cardiology 114 (2007) 78-82) |
| • |
EuroSCORE as a Predictor of Death and Myocardial Infarction
After Unprotected Left Main Coronary Stenting (Am J Cardiol 98 (2006)
1567- 1570) |
| • |
Two-Year Follow-up of the Quantitative Angiographic
and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric
Paclitaxel-Eluting Stent Implantation (J Am Coll Cariol 48 (2006)
2432-2439) |
| • |
Incidence and Predictors of Recurrent Restenosis Following
Implantation of Drug-Eluting Stents for In-Stent Restenosis (CCI 69
(2007) 104-108) |